palmidrol has been researched along with citalopram in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bystrowska, B; Filip, M; Gawliński, D; Pomierny, B; Smaga, I; Stankowicz, P | 1 |
| Afarideh, M; Akhondzadeh, S; Ardebili, ME; Ghajar, A; Ghaleiha, A; Ghazizadeh-Hashemi, F; Ghazizadeh-Hashemi, M; Malekpour, F; Shalbafan, MR | 1 |
1 trial(s) available for palmidrol and citalopram
| Article | Year |
|---|---|
Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial.
Topics: Adult; Amides; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Chemotherapy, Adjuvant; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Ethanolamines; Female; Humans; Male; Palmitic Acids; Treatment Outcome | 2018 |
1 other study(ies) available for palmidrol and citalopram
| Article | Year |
|---|---|
Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures.
Topics: Acetylcysteine; Amides; Amidohydrolases; Animals; Antidepressive Agents; Arachidonic Acids; Benzamides; Brain; Carbamates; Citalopram; Endocannabinoids; Enzyme Inhibitors; Ethanolamines; Expectorants; Glycerides; Imipramine; Male; Oleic Acids; Palmitic Acids; Polyunsaturated Alkamides; Rats, Wistar; Thiazepines | 2014 |